Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer

被引：0
|
作者：
Julia H. Carter
James A. Deddens
Gretchen Mueller
Thomas G. Lewis
Mariah K. Dooley
Michelle C. Robillard
Molly Frydl
Lydia Duvall
Jackson O. Pemberton
Larry E. Douglass
机构：
[1] Wood Hudson Cancer Research Laboratory,Department of Mathematical Sciences
[2] University of Cincinnati,undefined
[3] St. Elizabeth Healthcare,undefined
来源：
British Journal of Cancer | 2018年 / 119卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 470
页数：8
相关论文
共 50 条
  • [21] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    G Hofstetter
    A Berger
    H Fiegl
    N Slade
    A Zorić
    B Holzer
    E Schuster
    V J Mobus
    D Reimer
    G Daxenbichler
    C Marth
    A G Zeimet
    N Concin
    R Zeillinger
    Oncogene, 2010, 29 : 1997 - 2004
  • [22] INFREQUENCY OF RAS, P53, WT1, OR RB GENE ALTERATIONS IN WILMS-TUMORS
    WABER, PG
    CHEN, J
    NISEN, PD
    CANCER, 1993, 72 (12) : 3732 - 3738
  • [23] Combined analysis of p53 and RB pathways in epithelial ovarian cancer
    Hashiguchi, Y
    Tsuda, H
    Yamamoto, K
    Inoue, T
    Ishiko, O
    Ogita, S
    HUMAN PATHOLOGY, 2001, 32 (09) : 988 - 996
  • [24] p53 and WAF1 expression in epithelial ovarian cancer: Prognostic and predictive implications
    Katsaros, D
    Genta, F
    Durando, A
    Danese, S
    Ricchiardi, R
    Levesque, M
    Diamandis, EP
    Massobrio, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S22 - S22
  • [25] Are p53 mutations and p53 overexpression prognostic factors for astrocytic tumors?
    Ishii, N
    de Tribolet, N
    CRITICAL REVIEWS IN NEUROSURGERY, 1998, 8 (05) : 269 - 274
  • [26] WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis
    Kumar-Singh, S
    Segers, K
    Rodeck, U
    Backhovens, H
    Bogers, J
    Weyler, J
    Van Broeckhoven, C
    vanMarck, E
    JOURNAL OF PATHOLOGY, 1997, 181 (01): : 67 - 74
  • [27] Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer
    Bani-Hani, KE
    Almasri, NM
    Khader, YS
    Sheyab, FM
    Karam, HN
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1447 - 1453
  • [28] Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
    Lenos, Kristiaan
    Grawenda, Anna M.
    Lodder, Kirsten
    Kuijjer, Marieke L.
    Teunisse, Amina F. A. S.
    Repapi, Emmanouela
    Grochola, Lukasz F.
    Bartel, Frank
    Hogendoorn, Pancras C. W.
    Wuerl, Peter
    Taubert, Helge
    Cleton-Jansen, Anne-Marie
    Bond, Gareth L.
    Jochemsen, Aart G.
    CANCER RESEARCH, 2012, 72 (16) : 4074 - 4084
  • [29] PROGNOSTIC AFFECT OF P16 AND P53 EXPRESSIONS ON STAGE 1A EPITHELIAL OVARIAN CANCER
    Ayhan, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [30] NOTCH AND THE p53 CLAN OF TRANSCRIPTION FACTORS
    Roemer, Klaus
    NOTCH SIGNALING IN EMBRYOLOGY AND CANCER, 2012, 727 : 223 - 240
12345